1. 1. World Health Organization. Global Health Sector Strategy on Viral Hepatitis 2016-2020. https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf;jsessionid=5BF52293B12E4CCFB85FCE3FDE10440A?sequence=1 (accessed May 20, 2021).
2. 2. World Health Organization. Progress report on HIV, viral hepatitis and sexually transmitted infections 2019. Accountability for the global health sector strategies, 2016-2021. https://apps.who.int/iris/bitstream/handle/10665/324797/WHO-CDS-HIV-19.7-eng.pdf?ua=1 (accessed May 20, 2021).
3. 3. World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. https://apps.who.int/iris/rest/bitstreams/1348210/retrieve (accessed May 26, 2021).
4. 4. UNITAID. Technology and market landscape: hepatitis C medicines. https://unitaid.org/assets/HCV-Medicines-Landscape_Aug-2017.pdf (accesssed May 20, 2021). 1
5. 5. AASLD-IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015; 62:932-954.